![48985 - Homepage slide 48985 - Homepage slide](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/48985-Homepage-slide.png)
Driving MASH Drug Development & Navigating
the Evolving Metabolic & Obesity Landscape
The MASH field have hailed the very first approved MASH therapeutic with Madrigal’s drug gaining FDA approval this March opening the doors to a wave of therapeutics from Eli Lilly, Boehringer Ingelheim, AstraZeneca, Amgen, Akero Therapeutics and more that hold huge promise in phase 1, 2, and 3 clinical trials.  Paired with the boom of GLP-1s in the metabolic space, these milstones have reinvigorated investment in the space.
From optimizing clinical trial design, overcoming regulatory challenges, combatting fibrosis, navigating GLP-1 usage, optimizing RWE integration and achieving accurate non-invasive biomarkers, this Summit is your onestop-shop. The 8th MASH Drug Development Summit is the venue for the community to unite and discuss the evolving drug development opportunity for MASH and metabolic diseases.  
Across 2 conference days, with Preclinical and Translational, and Clinical and Regulatory tracks, a poster session, and an additional pre-conference workshop designed for innovation scouting, strategic portfolio partnering and networking with investors. Join 120+ C-Level cardiometabolic stakeholders and thought leaders to streamline the development of the six MASH late-stage assets in phrase 3 and a plethora of assets in phase 1-2.Â
Don’t miss this key opportunity to share the future of you MASH development pipeline! Â
Featuring 35+ World-Class Speakers
![](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Stephanie-Watkins-150x150.jpg)
![](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Rebecca-Taub.png)
![](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Kristin-Fiorino-150x150.jpg)
![](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Pitchumani-Sivakumar-150x150.jpg)
![](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Gerald-Horan-150x150.jpg)
Who's Attended in the Past?
![ASTRAZENECA ASTRAZENECA](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/ASTRAZENECA-1.jpg)
![Boehringer Ingelheim logo Boehringer Ingelheim logo](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Boehringer-Ingelheim-logo.png)
![PFIZER PFIZER](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/PFIZER.jpg)
![bms_logo_rgb_pos_300 bms_logo_rgb_pos_300](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/bms_logo_rgb_pos_300.png)
![BAYER BAYER](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/BAYER.png)
![Eli_Lilly_and_Company Eli_Lilly_and_Company](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Eli_Lilly_and_Company.png)
![Amgen-Logo Amgen-Logo](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Amgen-Logo-scaled.jpg)
![GILEAD GILEAD](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/GILEAD.png)
![Takeda_Pharmaceutical_Company_logo.svg Takeda_Pharmaceutical_Company_logo.svg](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Takeda_Pharmaceutical_Company_logo.svg_.png)
![Regeneron-social-logo-1200x630 Regeneron-social-logo-1200x630](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Regeneron-social-logo-1200x630-1.jpg)
![Akero Logo Akero Therapeutics, Inc. Logo](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Akero_Logo.jpg)
![89bio 89bio](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/89bio.png)
![INVENTIVA INVENTIVA](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/INVENTIVA.png)
![N_SGMT N_SGMT](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/N_SGMT.png)
Testimonials
Our Partners
![summit clinical research summit clinical research](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/summit-clinical-research.png)
![Antaros_Medical_logotype_RGB Antaros_Medical_logotype_RGB](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Antaros_Medical_logotype_RGB.png)
![Perspectum_Logo Perspectum_Logo](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Perspectum_Logo.jpg)
![Aragen_Logo_CMYK_Gradient Aragen_Logo_CMYK_Gradient](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/06/Aragen_Logo_CMYK_Gradient.png)
![physio physio](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/physio.jpg)
![Almac-logo-sq-300x300 Almac-logo-sq-300x300](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/Almac-logo-sq-300x300-1.png)
![KBI_Logo KBI_Logo](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/KBI_Logo.jpg)
![gubra gubra](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/05/gubra.jpg)
![LifeNet Health LifeNet Health](https://mashdrugdevelopmentsummit.com/wp-content/uploads/sites/147/2024/06/LifeNet-Health.png)